Intelligent Bio Solutions Stock Total Debt
| INBS Stock | USD 2.61 0.04 1.51% |
Intelligent Bio Solutions fundamentals help investors to digest information that contributes to Intelligent Bio's financial success or failures. It also enables traders to predict the movement of Intelligent Stock. The fundamental analysis module provides a way to measure Intelligent Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Intelligent Bio stock.
Total Debt To Capitalization is likely to gain to 0.31 in 2024. Intelligent | Total Debt |
Intelligent Bio Solutions Company Total Debt Analysis
Intelligent Bio's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current Intelligent Bio Total Debt | 1.34 M |
Most of Intelligent Bio's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Intelligent Bio Solutions is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Intelligent Total Debt Driver Correlations
Understanding the fundamental principles of building solid financial models for Intelligent Bio is extremely important. It helps to project a fair market value of Intelligent Stock properly, considering its historical fundamentals such as Total Debt. Since Intelligent Bio's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Intelligent Bio's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Intelligent Bio's interrelated accounts and indicators.
Click cells to compare fundamentals
Intelligent Total Debt Historical Pattern
Today, most investors in Intelligent Bio Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Intelligent Bio's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's total debt growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Intelligent Bio total debt as a starting point in their analysis.
Intelligent Bio Total Debt |
| Timeline |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
| Competition |
Intelligent Short Long Term Debt Total
Short Long Term Debt Total |
|
Based on the latest financial disclosure, Intelligent Bio Solutions has a Total Debt of 1.34 M. This is 99.95% lower than that of the Health Care Equipment & Supplies sector and 99.86% lower than that of the Health Care industry. The total debt for all United States stocks is 99.97% higher than that of the company.
Intelligent Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Intelligent Bio's direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Intelligent Bio could also be used in its relative valuation, which is a method of valuing Intelligent Bio by comparing valuation metrics of similar companies.Intelligent Bio is currently under evaluation in total debt category among related companies.
Intelligent Bio Current Valuation Drivers
We derive many important indicators used in calculating different scores of Intelligent Bio from analyzing Intelligent Bio's financial statements. These drivers represent accounts that assess Intelligent Bio's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Intelligent Bio's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Enterprise Value | 1.6B | 480.0M | 108.3M | 33.3M | 38.3M | 36.4M |
Intelligent Bio Institutional Holders
Institutional Holdings refers to the ownership stake in Intelligent Bio that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Intelligent Bio's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Intelligent Bio's value.| Shares | Geode Capital Management, Llc | 2023-09-30 | 12.4 K | Tower Research Capital Llc | 2023-09-30 | 5.9 K | Wells Fargo & Co | 2023-09-30 | 17.0 | Org Partners Llc | 2023-12-31 | 0.0 |
Intelligent Fundamentals
| Return On Equity | -2.0 | ||||
| Return On Asset | -0.45 | ||||
| Operating Margin | (2.61) % | ||||
| Current Valuation | 5.61 M | ||||
| Shares Outstanding | 2.84 M | ||||
| Shares Owned By Insiders | 1.59 % | ||||
| Shares Owned By Institutions | 4.45 % | ||||
| Number Of Shares Shorted | 73.49 K | ||||
| Price To Book | 2.64 X | ||||
| Price To Sales | 3.51 X | ||||
| Revenue | 1.26 M | ||||
| Gross Profit | 326.67 K | ||||
| EBITDA | (8.32 M) | ||||
| Net Income | (8.33 M) | ||||
| Cash And Equivalents | 8.28 M | ||||
| Cash Per Share | 0.56 X | ||||
| Total Debt | 1.34 M | ||||
| Current Ratio | 2.33 X | ||||
| Book Value Per Share | 2.22 X | ||||
| Cash Flow From Operations | (3.36 M) | ||||
| Short Ratio | 1.24 X | ||||
| Earnings Per Share | 64.68 X | ||||
| Target Price | 12.0 | ||||
| Number Of Employees | 51 | ||||
| Beta | 4.83 | ||||
| Market Capitalization | 7.65 M | ||||
| Total Asset | 12.35 M | ||||
| Retained Earnings | (31.18 M) | ||||
| Working Capital | (2.02 M) | ||||
| Net Asset | 12.35 M |
About Intelligent Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Intelligent Bio Solutions's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Intelligent Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Intelligent Bio Solutions based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Intelligent Bio Piotroski F Score and Intelligent Bio Altman Z Score analysis. Note that the Intelligent Bio Solutions information on this page should be used as a complementary analysis to other Intelligent Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Complementary Tools for Intelligent Stock analysis
When running Intelligent Bio's price analysis, check to measure Intelligent Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intelligent Bio is operating at the current time. Most of Intelligent Bio's value examination focuses on studying past and present price action to predict the probability of Intelligent Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intelligent Bio's price. Additionally, you may evaluate how the addition of Intelligent Bio to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Stocks Directory Find actively traded stocks across global markets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |
Is Intelligent Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Intelligent Bio. If investors know Intelligent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Intelligent Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 64.68 | Revenue Per Share 7.339 | Quarterly Revenue Growth 1.142 | Return On Assets (0.45) | Return On Equity (2.00) |
The market value of Intelligent Bio Solutions is measured differently than its book value, which is the value of Intelligent that is recorded on the company's balance sheet. Investors also form their own opinion of Intelligent Bio's value that differs from its market value or its book value, called intrinsic value, which is Intelligent Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Intelligent Bio's market value can be influenced by many factors that don't directly affect Intelligent Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Intelligent Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Intelligent Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Intelligent Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.